Osaic Holdings’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21 Hold
4
– – ﹤0.01% 7921
2026
Q1
$40 Buy
4
+1
+33% +$9 ﹤0.01% 7690
2025
Q4
$16 Hold
3
– – ﹤0.01% 7747
2025
Q3
$35 Buy
3
+1
+50% +$15 ﹤0.01% 7805
2025
Q2
$44 Hold
2
– – ﹤0.01% 7622
2025
Q1
$52 Hold
2
– – ﹤0.01% 7281
2024
Q4
$46 Sell
2
-2
-50% -$59 ﹤0.01% 7298
2024
Q3
$142 Hold
4
– – ﹤0.01% 7216
2024
Q2
$94 Hold
4
– – ﹤0.01% 7251
2024
Q1
$273 Sell
4
-2
-33% -$151 ﹤0.01% 6922
2023
Q4
$748 Sell
6
-4
-40% -$471 ﹤0.01% 6833
2023
Q3
$1.3K Hold
10
– – ﹤0.01% 6759
2023
Q2
$1.8K Sell
10
-1
-9% -$200 ﹤0.01% 6707
2023
Q1
$1.76K Buy
11
+2
+22% +$421 ﹤0.01% 6770
2022
Q4
$2K Sell
9
-11
-55% -$4.15K ﹤0.01% 6688
2022
Q3
$8K Buy
20
+5
+33% +$2.83K ﹤0.01% 6139
2022
Q2
$6K Hold
15
– – ﹤0.01% 6400
2022
Q1
$9K Hold
15
– – ﹤0.01% 6216
2021
Q4
$17K Buy
15
+7
+88% +$15.2K ﹤0.01% 5906
2021
Q3
$32K Buy
8
+3
+60% +$9.46K ﹤0.01% 5445
2021
Q2
$15K Sell
5
-11
-69% -$26K ﹤0.01% 5831
2021
Q1
$33K Buy
16
+10
+167% +$15K ﹤0.01% 5167
2020
Q4
$5K Sell
6
-8
-57% -$6.84K ﹤0.01% 5787
2020
Q3
$12K Buy
14
+10
+250% +$8.9K ﹤0.01% 5183
2020
Q2
$4K Hold
4
– – ﹤0.01% 5578
2020
Q1
$4K Buy
+4
New +$3.27K ﹤0.01% 5452

Other funds holding PAVM

Osaic Holdings's PAVM Position: Q2 2026 in Review

Osaic Holdings held its PAVmed (PAVM) position steady in Q2 2026 at 4 shares worth $21. The position accounts for ﹤0.01% of the portfolio, ranked #7921.

Osaic Holdings first reported a position in PAVM in Q1 2020 and has held it in 26 quarters since. The position peaked at $33K in Q1 2021. 19 funds tracked by Wall St. Rank hold PAVM as of Q2 2026.

  • Osaic Holdings held 4 shares of PAVmed worth $21 as of Q2 2026.
  • Osaic Holdings left its PAVmed share count unchanged in Q2 2026.
  • PAVmed made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7921 holding.
  • Osaic Holdings first reported a position in PAVmed in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's PAVmed position peaked at $33K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held PAVmed as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.